{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T09:53:18Z","timestamp":1787305998669,"version":"build-2736575974"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,18]],"date-time":"2023-06-18T00:00:00Z","timestamp":1687046400000},"content-version":"am","delay-in-days":352,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","award":["RO1FD003527"],"award-info":[{"award-number":["RO1FD003527"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","award":["DK066204"],"award-info":[{"award-number":["DK066204"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","award":["P30DK111024"],"award-info":[{"award-number":["P30DK111024"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","award":["U01 DK098246"],"award-info":[{"award-number":["U01 DK098246"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","award":["U01 DK091958"],"award-info":[{"award-number":["U01 DK091958"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","award":["IIR 07-138"],"award-info":[{"award-number":["IIR 07-138"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["PHILLI12A0"],"award-info":[{"award-number":["PHILLI12A0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007217","name":"Health Services Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007217","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000041","name":"American Diabetes Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["KL2TR002381"],"award-info":[{"award-number":["KL2TR002381"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1 TR002378"],"award-info":[{"award-number":["UL1 TR002378"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","award":["AI133172"],"award-info":[{"award-number":["AI133172"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","award":["R21DK099716"],"award-info":[{"award-number":["R21DK099716"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","award":["DK066204"],"award-info":[{"award-number":["DK066204"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","award":["P30DK111024"],"award-info":[{"award-number":["P30DK111024"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","award":["U01 DK091958"],"award-info":[{"award-number":["U01 DK091958"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","award":["U01 DK098246"],"award-info":[{"award-number":["U01 DK098246"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01CX001737"],"award-info":[{"award-number":["I01CX001737"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01-BX003340"],"award-info":[{"award-number":["I01-BX003340"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01-CX001025"],"award-info":[{"award-number":["I01-CX001025"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.diabres.2022.109935","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T11:30:08Z","timestamp":1654083008000},"page":"109935","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Potential misclassification of diabetes and prediabetes in the U.S.: Mismatched HbA1c and glucose in NHANES 2005\u20132016"],"prefix":"10.1016","volume":"189","author":[{"given":"Lisa R.","family":"Staimez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren M.","family":"Kipling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Nina Ham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian T.","family":"Legvold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra L.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W.F.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary K.","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence S.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2022.109935_b0005","doi-asserted-by":"crossref","unstructured":"American Diabetes Association (ADA), 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020. Diabetes Care, 2020;43(Suppl 1):S14-S31.","DOI":"10.2337\/dc20-S002"},{"issue":"7","key":"10.1016\/j.diabres.2022.109935_b0010","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1373\/clinchem.2018.296962","article-title":"The National Glycohemoglobin Standardization Program: Over 20 Years of Improving Hemoglobin A1c Measurement","volume":"65","author":"Little","year":"2019","journal-title":"Clin Chem"},{"issue":"11","key":"10.1016\/j.diabres.2022.109935_b0015","first-page":"1985","article-title":"The national glycohemoglobin standardization program: a five-year progress report","volume":"47","author":"Little","year":"2001","journal-title":"Clin Chem"},{"issue":"4","key":"10.1016\/j.diabres.2022.109935_b0020","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/BF00404798","article-title":"Unexplained variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia","volume":"33","author":"Yudkin","year":"1990","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2022.109935_b0025","doi-asserted-by":"crossref","DOI":"10.1111\/dme.13979","article-title":"Racial differences in performance of HbA1c for the classification of diabetes and prediabetes among US adults of non-Hispanic black and white race","author":"Ford","year":"2019","journal-title":"Diabet Med"},{"issue":"12","key":"10.1016\/j.diabres.2022.109935_b0030","doi-asserted-by":"crossref","first-page":"770","DOI":"10.7326\/0003-4819-152-12-201006150-00004","article-title":"Glucose-independent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies","volume":"152","author":"Ziemer","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diabres.2022.109935_b0035","doi-asserted-by":"crossref","unstructured":"Malka R, Nathan DM, Higgins JM, Mechanistic modeling of hemoglobin glycation and red blood cell kinetics enables personalized diabetes monitoring. Sci Transl Med, 2016;8(359):359ra130-359ra130.","DOI":"10.1126\/scitranslmed.aaf9304"},{"issue":"10","key":"10.1016\/j.diabres.2022.109935_b0040","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1182\/blood-2008-04-154112","article-title":"Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c","volume":"112","author":"Cohen","year":"2008","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.diabres.2022.109935_b0045","doi-asserted-by":"crossref","first-page":"95","DOI":"10.7326\/M16-2596","article-title":"Racial differences in the relationship of glucose concentrations and hemoglobin a1c levels","volume":"167","author":"Bergenstal","year":"2017","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.diabres.2022.109935_b0050","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.2337\/dc06-2003","article-title":"Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program","volume":"30","author":"Herman","year":"2007","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.diabres.2022.109935_b0055","doi-asserted-by":"crossref","first-page":"303","DOI":"10.7326\/0003-4819-154-5-201103010-00004","article-title":"Racial differences in glycemic markers: a cross-sectional analysis of community-based data","volume":"154","author":"Selvin","year":"2011","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.diabres.2022.109935_b0060","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.2337\/dc14-1844","article-title":"The Hemoglobin Glycation Index Identifies Subpopulations With Harms or Benefits From Intensive Treatment in the ACCORD Trial","volume":"38","author":"Hempe","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2022.109935_b0065","unstructured":"Zipf G et al. National Health and Nutrition Examination Survey: Plan and Operations, 1999-2010. National Center for Health Statistics. Vital Health Statistics, 2056(1)."},{"key":"10.1016\/j.diabres.2022.109935_b0070","unstructured":"National Center for Health Statistics and U.S. Department of Health and Human Services, National Health and Nutrition Examination Survey: Sample Design, 2011-2014, in Vital and Health Statistics,. 2014."},{"key":"10.1016\/j.diabres.2022.109935_b0075","unstructured":"Centers for Disease Control and Prevention, Oral Glucose Tolerance Test: Trutol Administration. 2016."},{"issue":"11","key":"10.1016\/j.diabres.2022.109935_b0080","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2337\/db10-1032","article-title":"Pathogenesis of fasting and postprandial hyperglycemia in type 2 diabetes: implications for therapy","volume":"59","author":"Rizza","year":"2010","journal-title":"Diabetes"},{"issue":"14","key":"10.1016\/j.diabres.2022.109935_b0085","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Diabetes","year":"1993","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.diabres.2022.109935_b0090","doi-asserted-by":"crossref","first-page":"968","DOI":"10.2337\/diab.44.8.968","article-title":"The Relationship of Glycemic Exposure (HbA1c) to the Risk of Development and Progression of Retinopathy in the Diabetes Control and Complications Trial","volume":"44","author":"The Diabetes Control and Complications Trial Research Group","year":"1995","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.diabres.2022.109935_b0095","doi-asserted-by":"crossref","first-page":"995","DOI":"10.2337\/db07-1618","article-title":"Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial\u2013revisited","volume":"57","author":"Lachin","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2022.109935_b0100","unstructured":"National Center for Health Statistics, Analytic Note Regarding 2007-2010 Survey Design Changes and Combining Data Across other Survey Cycles C.f.D.C.a. Prevention, Editor. 2011."},{"key":"10.1016\/j.diabres.2022.109935_b0105","unstructured":"Johnson C et al., National Health and Nutrition Examination Survey: Analytic Guidelnes, 1999-2010. Vital Health Statistics, 2013. 2(161)."},{"key":"10.1016\/j.diabres.2022.109935_b0110","unstructured":"Chen TC et al., National Health and Nutrition Examination Survey: Estimation Procedures, 2011-2014. Vital Health Stat 2, 2018(177): 1-26."},{"key":"10.1016\/j.diabres.2022.109935_b0115","first-page":"1","article-title":"National Center for Health Statistics Data Presentation Standards for Proportions","volume":"175","author":"Parker","year":"2017","journal-title":"Vital Health Stat 2"},{"issue":"7","key":"10.1016\/j.diabres.2022.109935_b0120","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nrendo.2017.3","article-title":"Metrics for glycaemic control - from HbA1c to continuous glucose monitoring","volume":"13","author":"Kovatchev","year":"2017","journal-title":"Nat Rev Endocrinol"},{"issue":"8","key":"10.1016\/j.diabres.2022.109935_b0125","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1177\/2047487317692664","article-title":"The haemoglobin glycation index as predictor of diabetes-related complications in the AleCardio trial","volume":"24","author":"van Steen","year":"2017","journal-title":"Eur J Prev Cardiol"},{"issue":"8","key":"10.1016\/j.diabres.2022.109935_b0130","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1210\/jc.2017-00191","article-title":"Hemoglobin Glycation Index Is Associated With Cardiovascular Diseases in People With Impaired Glucose Metabolism","volume":"102","author":"Ahn","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.diabres.2022.109935_b0135","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1056-8727(01)00227-6","article-title":"High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control","volume":"16","author":"Hempe","year":"2002","journal-title":"J Diabetes Complications"},{"issue":"9","key":"10.1016\/j.diabres.2022.109935_b0140","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.2337\/dc05-1973","article-title":"Disparities in HbA1c levels between African-American and non-Hispanic white adults with diabetes","volume":"29","author":"Kirk","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2022.109935_b0145","doi-asserted-by":"crossref","DOI":"10.7326\/M16-2596","article-title":"Racial Differences in the Relationship of Glucose Concentrations and Hemoglobin A1c Levels","author":"Bergenstal","year":"2017","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.diabres.2022.109935_b0150","doi-asserted-by":"crossref","first-page":"994","DOI":"10.2337\/dc17-0636","article-title":"The Fallacy of Average: How Using HbA1c Alone to Assess Glycemic Control Can Be Misleading","volume":"40","author":"Beck","year":"2017","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.diabres.2022.109935_b0155","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.2337\/dc15-2727","article-title":"Role of Glycated Proteins in the Diagnosis and Management of Diabetes: Research Gaps and Future Directions","volume":"39","author":"Welsh","year":"2016","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.diabres.2022.109935_b0160","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2337\/dc08-2220","article-title":"Labile A1C is inversely correlated with the hemoglobin glycation index in children with type 1 diabetes","volume":"33","author":"Chalew","year":"2010","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.diabres.2022.109935_b0165","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.2337\/dc06-0286","article-title":"Evidence for independent heritability of the glycation gap (glycosylation gap) fraction of HbA1c in nondiabetic twins","volume":"29","author":"Cohen","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2022.109935_b0170","doi-asserted-by":"crossref","unstructured":"Leong APD, Charest B, Higgins JM, Rhee MK, Meigs JB, Hemoglobin A1c (A1c) genetics contributes to A1c\/glucose mismatches in the multiethnic VA Million Veteran Program (MVP), in Published Abstract, 78th Scientific Sessions of the American Diabetes Association. 2018, American Diabetes Association.","DOI":"10.2337\/db18-183-LB"},{"issue":"2","key":"10.1016\/j.diabres.2022.109935_b0175","doi-asserted-by":"crossref","first-page":"131","DOI":"10.7326\/M17-1231","article-title":"Variability in the Relationship of Hemoglobin A1c and Average Glucose Concentrations: How Much Does Race Matter?","volume":"167","author":"Selvin","year":"2017","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.diabres.2022.109935_b0180","doi-asserted-by":"crossref","first-page":"e1002383","DOI":"10.1371\/journal.pmed.1002383","article-title":"Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis","volume":"14","author":"Wheeler","year":"2017","journal-title":"PLoS Med"},{"issue":"5","key":"10.1016\/j.diabres.2022.109935_b0185","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2016.21035","article-title":"Association of sickle cell trait with hemoglobin A1c in African Americans","volume":"317","author":"Lacy","year":"2017","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.diabres.2022.109935_b0190","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/000456329803500107","article-title":"The reproducibility and usefulness of the oral glucose tolerance test in screening for diabetes and other cardiovascular risk factors","volume":"35","author":"Ko","year":"1998","journal-title":"Ann Clin Biochem"},{"issue":"1","key":"10.1016\/j.diabres.2022.109935_b0195","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0168-8227(99)00008-X","article-title":"Diagnostic criteria for diabetes mellitus and other categories of glucose intolerance: 1997 criteria by the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (ADA), 1998 WHO Consultation criteria, and 1985 WHO criteria","volume":"44","author":"Puavilai","year":"1999","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"10.1016\/j.diabres.2022.109935_b0200","doi-asserted-by":"crossref","first-page":"562","DOI":"10.2337\/dc09-1524","article-title":"Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988\u20132006","volume":"33","author":"Cowie","year":"2010","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.diabres.2022.109935_b0205","doi-asserted-by":"crossref","first-page":"604","DOI":"10.2337\/dc17-2252","article-title":"Characteristics Associated With Decreased or Increased Mortality Risk From Glycemic Therapy Among Patients With Type 2 Diabetes and High Cardiovascular Risk: Machine Learning Analysis of the ACCORD Trial","volume":"41","author":"Basu","year":"2018","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.diabres.2022.109935_b0210","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1007\/s00125-017-4539-1","article-title":"Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial","volume":"61","author":"van Steen","year":"2018","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.diabres.2022.109935_b0215","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2021-002339","article-title":"Hemoglobin glycation index, calculated from a single fasting glucose value, as a prediction tool for severe hypoglycemia and major adverse cardiovascular events in DEVOTE","volume":"9","author":"Klein","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"7","key":"10.1016\/j.diabres.2022.109935_b0220","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.2337\/db07-0028","article-title":"The hemoglobin glycation index is not an independent predictor of the risk of microvascular complications in the Diabetes Control and Complications Trial","volume":"56","author":"Lachin","year":"2007","journal-title":"Diabetes"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822722007495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822722007495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:49:07Z","timestamp":1778629747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822722007495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":44,"alternative-id":["S0168822722007495"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2022.109935","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential misclassification of diabetes and prediabetes in the U.S.: Mismatched HbA1c and glucose in NHANES 2005\u20132016","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2022.109935","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109935"}}